Alemtuzumab (Campath-1H) in therapy of CLL / Kanti R. Rai.

Format:

Video

Author/Creator:

Rai, Kanti R., speaker, author.

Series:

Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances.

Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, 2056-452X

Language:

English

Subjects (All):

Antibodies, Monoclonal--therapeutic use.

Leukemia, Lymphocytic, Chronic, B-Cell--therapy.

Medical Subjects:

Antibodies, Monoclonal--therapeutic use.

Leukemia, Lymphocytic, Chronic, B-Cell--therapy.

Genre:

Video recordings.

Physical Description:

1 online resource (1 streaming video file (26 min.)) : color, sound.

polychrome

Other Title:

Alemtuzumab (Campath-1H) in therapy of chronic lymphocytic leukemia

Place of Publication:

London : Henry Stewart Talks, 2007.

System Details:

Mode of access: World Wide Web.

video file

Contents:

Contents: Development of Campath-1H

Burroughs-Wellcome Era (BW)

Millenium (LeukosSite)-Ilex Era (MI)

Differences between BW era and MI era

The two main trials in the BW era: study 005 in European countries and study 009 in the USA

Responses to these trials

Complications of these trials: opportunistic infection

MI era results from 1998 and study 211 (which incorporated prophylaxis against opportunistic infections)

Efficacy of Campath-1H

Examination of bone marrow biopsy specimens

Survival times

Infectious complications after first-line therapy with Campath-1H

CMV guidelines

CALGB trial.

Notes:

Animated audio-visual presentation with synchronized narration.

Title from title frames.

Publisher Number:

1244 Henry Stewart Talks

Access Restriction:

Restricted for use by site license.